 | • レポートコード：B-MOR-040931 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、先進創傷治療管理の世界市場について調べ、先進創傷治療管理の世界規模、市場動向、市場環境、製品別（湿式創傷被覆材、アクティブ創傷治療、治療機器）分析、創傷の種類別（糖尿病性足潰瘍、圧迫潰瘍、静脈性下肢潰瘍、動脈性潰瘍、外科的創傷、火傷、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・先進創傷治療管理の世界市場インサイト ・先進創傷治療管理の世界市場環境 ・先進創傷治療管理の世界市場動向 ・先進創傷治療管理の世界市場規模 ・先進創傷治療管理の世界市場規模：製品別（湿式創傷被覆材、アクティブ創傷治療、治療機器） ・先進創傷治療管理の世界市場規模：創傷の種類別（糖尿病性足潰瘍、圧迫潰瘍、静脈性下肢潰瘍、動脈性潰瘍、外科的創傷、火傷、その他） ・先進創傷治療管理の世界市場：地域別市場規模・分析 ・先進創傷治療管理の北米市場規模・予測 ・先進創傷治療管理のアメリカ市場規模・予測 ・先進創傷治療管理のヨーロッパ市場規模・予測 ・先進創傷治療管理のアジア市場規模・予測 ・先進創傷治療管理の日本市場規模・予測 ・先進創傷治療管理の中国市場規模・予測 ・先進創傷治療管理のインド市場規模・予測 ・先進創傷治療管理の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global advance wound care management market is expected to register a CAGR of 6.25% during the forecast period 2018 to 2023. With more than 35% of the market share, North America is expected to dominate the market in the forecast period this is due to increasing incidences of chronic wounds along with favorable reimbursement policies in this region.
Increasing Number of Chronic Wounds, Ulcers and Diabetic Ulcers
According to NCBI, more than 9.3 percent of United States population which is estimated around 29.1 million people, is affected by diabetes. In adults who are aged over 65 years, the percent of population suffering with diabetes is more than 25 percent. The incidence of chronic wounds especially foot ulcers increases among the diabetic population. While more than 80,000 adults are expected to undergo a lower extremity amputation, It is also estimated that patient with diabetes are 10 times more likely to undergo amputation at some point in their life. The number of diabetes patients are expected to increase with increasing geriatric population which in turn will drive the market for wound care management in the forecast period.
In addition, increase in surgical procedures worldwide along with increasing ageing population is also fuelling the growth of advance wound care management market.
High Treatment Costs
Wound care management is associated with high costs due to which it has a low adoption rate. According to a breakdown of wound costs provided by Smith & Nephew, 15-20% are material costs, 30-35% are nurse costs and more than 50% are hospitalization costs. Since, the hospitalization in necessary until the wound is dried, the high hospitalization costs is hindering the advance wound care management market globally.
Additionally, lack of reimbursement policies all over the world is also responsible for hindering the growth of market.
North America to Dominate the Market
The Advance Wound Care Management market is segmented by product type, wound type, and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the advance wound care management market due to increasing incidences of chronic wounds, favorable reimbursement policies and rise in geriatric population. Europe is also expected to boost the growth of advance wound care management market due to increasing awareness of wound care management among geriatric population. Factors such as increasing accessibility to healthcare facilities in the region, rising medical tourism, and increasing prevalence of chronic diseases are also expected to contribute to the growth of market in this region.
Key Developments in the Market
• December 2017: Smith & Nephew announced European launch of MolecuLight i:X, which is a handheld imaging device that can be used to instantly measure wound surface area and visualize the presence of potentially harmful bacteria in it.
Key players: CONVATEC GROUP PLC, ACELITY, SMITH & NEPHEW, MOLNLYCKE HEALTH CARE AB, 3M COMPANY, COLOPLAST, DERMA SCIENCES INC., BAXTER INTERNATIONAL, and INTEGRA LIFESCIENCES.
Reasons to Purchase this Report
• Market analysis for the Global Advance Wound Care Management Market, with region-specific assessments and competition analysis on a global and regional scale.
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING INCIDENCES OF CHRONIC WOUNDS, ULCERS AND DIABETIC ULCERS
6.1.2 INCREASE IN VOLUME OF SURGICAL PROCEDURES WORLDWIDE
6.1.3 INCREASE IN AGEING POPULATION
6.2 MARKET RESTRAINTS
6.2.1 LACK OF REIMBURSEMENTS POLICIES
6.2.2 HIGH TREATMENT COSTS
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 SEGMENTATION-BY PRODUCT
7.1.1 MOIST WOUND DRESSINGS
7.1.1.1 FILM DRESSINGS
7.1.1.2 FOAMS DRESSINGS
7.1.1.3 HYDROCOLLOID DRESSINGS
7.1.1.4 HYDROGEL DRESSINGS
7.1.1.5 COLLAGEN DRESSINGS
7.1.1.6 ALGINATE DRESSINGS
7.1.1.7 SILVER WOUND DRESSINGS
7.1.2 ACTIVE WOUND CARE
7.1.2.1 SKIN SUBSTITUTES
7.1.2.2 GROWTH FACTORS
7.1.3 THERAPY DEVICES
7.1.3.1 NEGATIVE PRESSURE WOUND THERAPY
7.1.3.2 PRESSURE RELIEF DEVICES
7.1.3.3 OTHERS
7.2 SEGMENTATION-BY WOUND TYPE
7.2.1 DIABETIC FOOT ULCER
7.2.2 PRESSURE ULCER
7.2.3 VENOUS LEG ULCER
7.2.4 ARTERIAL ULCER
7.2.5 SURGICAL WOUNDS
7.2.6 BURNS
7.2.7 OTHERS
7.3 SEGMENTATION-BY GEOGRAPHY
7.3.1 NORTH AMERICA
7.3.1.1 UNITED STATES
7.3.1.2 CANADA
7.3.1.3 MEXICO
7.3.2 EUROPE
7.3.2.1 FRANCE
7.3.2.2 GERMANY
7.3.2.3 UNITED KINGDOM
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF EUROPE
7.3.3 ASIA-PACIFIC
7.3.3.1 CHINA
7.3.3.2 JAPAN
7.3.3.3 INDIA
7.3.3.4 AUSTRALIA & NEW ZEALAND
7.3.3.5 SOUTH KOREA
7.3.3.6 REST OF ASIA-PACIFIC
7.3.4 MIDDLE EAST & AFRICA
7.3.4.1 GCC
7.3.4.2 SOUTH AFRICA
7.3.4.3 REST OF THE MIDDLE EAST & AFRICA
7.3.5 SOUTH AMERICA
7.3.5.1 BRAZIL
7.3.5.2 ARGENTINA
7.3.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. KEY PLAYERS
9.1 CONVATEC GROUP PLC
9.2 ACELITY
9.3 SMITH & NEPHEW
9.4 MOLNLYCKE HEALTH CARE AB
9.5 3M COMPANY
9.6 COLOPLAST
9.7 DERMA SCIENCES INC.
9.8 BAXTER INTERNATIONAL
9.9 INTEGRA LIFESCIENCES
9.10 OTHERS
10. FUTURE OF THE MARKET